Home

Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer

Daniel Carlson -
0
TW's Take: this is a coming out party of sorts for Aevitas, another partner company in Fortress' stable. The "alternative complement pathway" space is...
Read more

Trading Blog, Feb. 25th 2021

Daniel Carlson -
2
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to...
Read more

Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a Wholly-owned Subsidiary of...

Daniel Carlson -
0
TW's Take: $20M into the coffers of Fortress Bio (FBIO) along with a PRV worth around $100M by the summer of 2023 is great...
Read more

Miami Advice

Daniel Carlson -
7
The past year has been all about the pandemic. First it was about selling everything. Like every other market meltdown, it was viewed as...
Read more

TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States...

Daniel Carlson -
0
TW's Take: These are very important data as TFF continues to prove the viability of the thin film freezing technology in vaccine development. The...
Read more

Trading Blog, Feb. 18th, 2021

Daniel Carlson -
1
I thought I'd put out a lengthier note today as I have gotten a lot of new subscribers over the last month and they...
Read more

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

Daniel Carlson -
0
TW's Take: with various strains of Covid-19 appearing, one could see the disease being here for many years and a therapeutic being greatly needed....
Read more

Heard On The Street

Daniel Carlson -
10
When I started in this business in the 1980s, "Heard on the Street" was a market moving column in the Wall Street Journal. R....
Read more

LexaGene Announces Change in Management and Appoints New Member to the Board of Directors

Daniel Carlson -
0
TW's Take: this is really a non-event for LexaGene, in terms of the business, however it is nice to get someone with a very...
Read more

HJLI Tried To Ruin 2019 For Me…2021 Should Be A Different Story

Daniel Carlson -
10
Yes, I'm back in Hancock Jaffe (HJLI). After taking major losses last year in the stock, I've decided to jump back in the pool....
Read more

Atomera Provides Fourth Quarter and Fiscal 2020 Results

Daniel Carlson -
0
TW's Take: nothing exciting in this report...just that the company continues to execute on their business plan. The rest of the year should see...
Read more

LEXAGENE’S MIQLAB SUCCESSFULLY DETECTS MUTANT UK AND SOUTH AFRICAN COVID-19 SEQUENCES

Daniel Carlson -
0
TW's Take: while they will not incorporate these tests into their EUA application, LexaGene will be able to roll out additional tests broadly post...
Read more

Sequans Communications Announces Fourth Quarter 2020 and Full Year 2020 Financial Results

Daniel Carlson -
0
TW's Take: SQNS is setting up for a very big 2021. Guidance of 50% annual revenue growth over the next 4 years makes this...
Read more

Riding the Waves

Daniel Carlson -
4
This is without a doubt the most amazing market of my career. It's obviously a bull market as indexes continue to head higher. But,...
Read more

Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked...

Daniel Carlson -
0
TW's Take: nice to have the clinical hold removed, allowing this program to proceed. MBIO is a compelling valuation (thanks to PRVs) in biotech,...
Read more

The GameStop Impact…January In Review

Daniel Carlson -
8
What a crazy way to end a wild month, huh? As GameStop (GME) continued to rally in the face of shorts, Robin Hood required...
Read more

Sequans Receives Major Funding Award for 5G Development From French Government

Daniel Carlson -
0
TW's Take: a solid endorsement of SQNS' technology, this grant leaves them likely fully-funded as they are guiding towards breakeven sometime around year end...
Read more

ParkerVision Gets Inside Track On Intel In Markman Ruling

Daniel Carlson -
5
A Markman Hearing is a pretrial hearing in a U.S. District Court during which a judge examines evidence to determine the appropriate meanings of relevant key...
Read more

Trading Blog, Jan. 26, 2021

Daniel Carlson -
0
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to...
Read more

Texas Court’s Markman Ruling Favorable for ParkerVision

Daniel Carlson -
0
TW's Take: this is great news for PRKR. Not only does it set them up very well in this large patent case versus Intel,...
Read more

Become a TW Research Member

All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.

For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $250 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.

SIGN ME UP

Receive Our Weekly Newsletter

Every Sunday we recap the market and consolidate the news from our universe. It’s free to subscribe. Just click on the link below.

Newsletter Signup

© TW Research Group LLC
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.